| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syros Pharmaceuticals, Inc. (SYRS) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. SYRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | Roth David | Chief Medical Officer | Sell | 10,451 | $4.95 | $51,732.45 | -100% | |
| Apr 2, 2024 | Roth David | Chief Medical Officer | Sale+OE | 150 | $4.98 | $747.05 | -1.4% | |
| Dec 21, 2023 | Akkaraju Srinivas81 | Director | Buy | 904,977 | $4.42 | $3,999,998.34 | +102.7% | |
| Dec 12, 2023 | Roth David | Chief Medical Officer | Sell | 6,287 | $4.95 | $31,120.65 | -100% | |
| Dec 6, 2023 | Roth David | Chief Medical Officer | Sell | 6,287 | $3.95 | $24,833.65 | -50.0% | |
| Jul 31, 2023 | Roth David | Chief Medical Officer | Sell | 7,348 | $3.95 | $29,024.60 | -100% | |
| Jul 17, 2023 | Olson Eric R | Chief Scientific Officer | Sell | 689 | $3.50 | $2,411.50 | -9.4% | |
| Sep 30, 2022 | Tyson Timothy | Director | Buy | 16,932 | $6.26 | $105,955.47 | +89.4% | |
| Jan 5, 2022 | Olson Eric R | Chief Scientific Officer | Sell | 2,208 | $3.47 | $7,654.92 | -100% | |
| Jul 1, 2021 | Olson Eric R | Chief Scientific Officer | Sell | 1,164 | $5.55 | $6,460.20 | -100% |